Real-World Treatment Adherence and Persistence with C5 Inhibitor Therapy Versus Satralizumab in Patients with Neuromyelitis Optica Spectrum Disorder in Japan.
Saved in:
| Title: | Real-World Treatment Adherence and Persistence with C5 Inhibitor Therapy Versus Satralizumab in Patients with Neuromyelitis Optica Spectrum Disorder in Japan. |
|---|---|
| Authors: | Chihara, Norio1 (AUTHOR), Lee, Justin2 (AUTHOR), Yu, Jeffrey C.2 (AUTHOR), Numajiri, Naoki3 (AUTHOR) naoki.numajiri@alexion.com, Misu, Tatsuro4 (AUTHOR) |
| Source: | Neurology & Therapy. Aug2026, Vol. 15 Issue 4, p1539-1555. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
